Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cervical Cancer
  Free Subscription

Articles published in
PLoS One
    January 2025
  1. DE FOUW M, Boere MWM, Nakisige C, Nabwire M, et al
    Cervical cancer care at a tertiary oncology facility in Uganda: Comparing daily practice with national treatment targets on cervical cancer control.
    PLoS One. 2025;20:e0316323.
    >> Share

  2. TAKAHASHI Y, Sasamori Y, Higuchi R, Kaku A, et al
    Effects of different educational interventions on cervical cancer knowledge and human papillomavirus vaccination uptake among young women in Japan: Preliminary results of a cluster randomized controlled trial.
    PLoS One. 2025;20:e0311588.
    >> Share

  3. KHOMPHAIBOONKIJ U, Sreamsukcharoenchai N, Pitakkarnkul S, Rittiluechai K, et al
    Correction: Knowledge of Thai women in cervical cancer etiology and screening.
    PLoS One. 2025;20:e0318184.
    >> Share

  4. ASIRWA FC, Bresnahan BW, Yego F, Duncan D, et al
    A prospective model of the potential clinical and economic impact of cervical cancer screening supported by a mobile phone app.
    PLoS One. 2025;20:e0316001.
    >> Share

  5. DEMEKE AD, Deribe B, Girma M, Gizaw M, et al
    Screening attendance of breast or cervical cancers and its associated factors among 30-49 year old women in Gedeo zone, South Ethiopia: Cross-sectional study.
    PLoS One. 2025;20:e0315891.
    >> Share

  6. UM S, Sopheab H
    Breast and cervical cancer screening among women at reproductive age in Cambodia: A secondary analysis of Cambodia Demographic and Health Survey 2022.
    PLoS One. 2025;20:e0295881.
    >> Share


  7. Retraction: Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to EZH2 and Repressing E-Cadherin in Cervical Cancer.
    PLoS One. 2025;20:e0318789.
    >> Share

  8. OPITO R, Tiyo Ayikobua E, Akurut H, Alwedo S, et al
    Factors associated with uptake and acceptability of cervical cancer screening among female sex workers in Northeastern Uganda: A cross-sectional study.
    PLoS One. 2025;20:e0312988.
    >> Share

  9. GAO Y, Liang G, Chang C, Pan F, et al
    Analysis of cervical and breast cancer screening behavior and its influencing factors among urban and rural women in Beijing.
    PLoS One. 2025;20:e0316898.
    >> Share

  10. WAGNER GJ, Bogart LM, Matovu JKB, Gwokyalya V, et al
    Study protocol for a hybrid implementation-effectiveness trial of Game Changers for Cervical Cancer Prevention in Uganda.
    PLoS One. 2025;20:e0317491.
    >> Share

  11. PANERU B, Karmacharya A, Bharati A, Makaju S, et al
    Correction: Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal.
    PLoS One. 2025;20:e0318367.
    >> Share

  12. AYTAC S, Ozbey G
    Photodiagnosis and photodynamic recognition of cervical cancer with SEM and AFM images.
    PLoS One. 2025;20:e0316544.
    >> Share

  13. HAMZA MN, Tariqul Islam M, Lavadiya S, Ud Din I, et al
    Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime.
    PLoS One. 2025;20:e0311431.
    >> Share

  14. MALOBA M, Finocchario-Kessler S, Wexler C, Staggs V, et al
    The Cancer Tracking System (CATSystem): Study protocol of a randomized control trial to evaluate a systems level intervention for cervical cancer screening, treatment, referral and follow up in Kenya.
    PLoS One. 2025;20:e0318941.
    >> Share

  15. REMMEL ML, Suija K, Markina A, Tisler A, et al
    Navigating the risks: Stakeholder views on risk-based cervical cancer screening.
    PLoS One. 2025;20:e0317986.
    >> Share

  16. ASIIMWE S, Bagenda FN, Mugisa T
    Factors associated with uptake of human papilloma virus vaccine among adolescent girls: A cross sectional survey on insights into HPV Infection Prevention in Kabarole District, Western Uganda.
    PLoS One. 2025;20:e0306960.
    >> Share

  17. ETEMADIFAR M, Shoeib S, Salari M, Etemadifar M, et al
    Gynecologic health of women with multiple sclerosis: An overview on the current status and findings of Pap tests in a low-income setting.
    PLoS One. 2025;20:e0320069.
    >> Share

  18. KIDAYA BN, Mwanga JR, Muhini OO, Mwaisungu HM, et al
    Healthcare-seeking behaviors and factors influencing non-adherence among cervical cancer patients attending Bugando Oncology Clinic in Mwanza, Tanzania: A qualitative Phenomenological study.
    PLoS One. 2025;20:e0317609.
    >> Share

  19. XIE R, Xie K, Lin X, Ji Y, et al
    A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited setting.
    PLoS One. 2025;20:e0319405.
    >> Share

  20. BURKE-GARCIA A, Cutroneo E, Afanaseva D, Madden K, et al
    Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages.
    PLoS One. 2025;20:e0319160.
    >> Share

  21. MAFI S, Theuillon F, Meyer S, Woillard JB, et al
    Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples.
    PLoS One. 2025;20:e0320978.
    >> Share

  22. AVILA E, Hernandez-Monterde LD, Cedro-Tanda A, Lizardi-Aguilera TM, et al
    Transcriptomic profile induced by calcitriol in CaSki human cervical cancer cell line.
    PLoS One. 2025;20:e0319812.
    >> Share

  23. WANG G, Jia C, Wang D, Liang L, et al
    Scutellaria Barbata inhibits epithelial-mesenchymal transformation through PI3K/AKT and MDM2 thus inhibiting the proliferation, migration and promoting apoptosis of Cervical Cancer cells.
    PLoS One. 2025;20:e0321556.
    >> Share

  24. ABATE A, Munshea A, Nibret E, Bezabih B, et al
    Evaluation of Onco E6 point of care rapid diagnostic test for human papilloma virus in Bahir Dar, Amhara Regional State, Ethiopia.
    PLoS One. 2025;20:e0321076.
    >> Share

  25. BAASLAND I, Bjorge T, Engesaeter B, Trope A, et al
    Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment.
    PLoS One. 2025;20:e0320739.
    >> Share

  26. MELAKU A, Abebe SN, Haile S
    Utilization of screening services on cervical cancer and associated factors among female health workers in Addis Ababa, Ethiopia.
    PLoS One. 2025;20:e0321662.
    >> Share

  27. ZHOU Q, Song B, He Y, Zhang Z, et al
    Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in cervical cancer.
    PLoS One. 2025;20:e0322387.
    >> Share

  28. RAPAJIC-MORAN I, Filipic B, Rajkovic D, Rakic M, et al
    Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach.
    PLoS One. 2025;20:e0322584.
    >> Share

  29. NOREEN K, Khalid SN, Javaid M, Khan SA, et al
    Public Health Implications of Introducing Human Papillomavirus (HPV) Vaccination in Pakistan: A protocol for a mixed-method study to explore community perceptions and health system preparedness.
    PLoS One. 2025;20:e0323826.
    >> Share

  30. ZARGARAN H, Ghaemi A, Shenagari M, Samadi M, et al
    Boosting immune response against cervical cancer: A combined approach using oncolytic virus and targeted therapies.
    PLoS One. 2025;20:e0312979.
    >> Share

  31. DANIELS J, Kyei KA, Frimpong-Boateng PD, Nyantakyi AY, et al
    Sexual function outcomes in prostate and cervical cancer patients treated with radiotherapy in sub-Saharan Africa: A cross-sectional study.
    PLoS One. 2025;20:e0324662.
    >> Share

  32. CASTELLANO T, ElHabr AK, Washington C, Ting J, et al
    Correction: Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US.
    PLoS One. 2025;20:e0324971.
    >> Share

  33. GOVINDSAMY K, Noll S, Blose N, Amponsah-Dacosta E, et al
    Effectiveness of integrating cervical cancer prevention strategies into HIV care programmes: A mixed-methods systematic review protocol.
    PLoS One. 2025;20:e0306496.
    >> Share

  34. SHI Y, Zhang L, Zhou Y, Liao X, et al
    A cross-sectional study of factors influencing sexual health among spouses of patients with cervical cancer.
    PLoS One. 2025;20:e0322141.
    >> Share

  35. ILIC I, Babic G, Sipetic Grujicic S, Zivanovic Macuzic I, et al
    Validity of the process and outcome specific measure in women with abnormal Papanicolaou screening test.
    PLoS One. 2025;20:e0325131.
    >> Share

  36. ELBASYOUNI A, Kyama MC, El-Shemy HA, Mwitari PG, et al
    Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer.
    PLoS One. 2025;20:e0323680.
    >> Share

  37. ENYEW EB, Kasaye MD, Kebede SD, Feyisa MS, et al
    Human Papillomavirus Vaccination uptake and associated factors among schools girls aged between 9-14 years in Ethiopia: Performance Monitoring for Action (PMA-ET) 2023, multilevel analysis.
    PLoS One. 2025;20:e0325557.
    >> Share

  38. ISLAM T, Khan MAS, Hawlader MDH, Meem NE, et al
    Awareness about cervical cancer and its socio-economic determinants among adults in Bangladesh: Results from a nationwide cross-sectional study.
    PLoS One. 2025;20:e0325712.
    >> Share

  39. SHAN Y, Abulikemu G, Liu L, Zhang Y, et al
    Risk factors associated with adverse outcomes after cervical conization in patients with cervical adenocarcinoma in situ.
    PLoS One. 2025;20:e0325748.
    >> Share

  40. YANG Y, Lu Y, Li Y, Qin C, et al
    Factors affecting caregivers' HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT.
    PLoS One. 2025;20:e0324260.
    >> Share

  41. PATURY P, Russomano FB, Moreira MAM, Kappaun NRC, et al
    Associations between genetic HPV 16 diversity and cervical cancer prognosis.
    PLoS One. 2025;20:e0308895.
    >> Share

  42. ARRIVILLAGA M, Torres MDM, Neira D, Garcia-Cifuentes JP, et al
    Patient acceptability of CITOBOT for cervical cancer screening: A mixed-method study.
    PLoS One. 2025;20:e0325805.
    >> Share

  43. RANA T, Chan DNS, Law BMH, Choi KC, et al
    Determinants of cervical cancer screening utilisation among women in the least developed countries: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0321627.
    >> Share

  44. YAO Y, Chen Y, Yang A, Ye Y, et al
    MVT-Net: A novel cervical tumour segmentation using multi-view feature transfer learning.
    PLoS One. 2025;20:e0325424.
    >> Share

  45. NDJENGUE BENGONE BC, Toniolo J, Filankembo Kava AC, Ngoungou EB, et al
    Psychological repercussions of breast or uterine cervical cancer disclosure to women in Gabon.
    PLoS One. 2025;20:e0326378.
    >> Share

  46. HASAN MM, Islam MH
    Herd immunity and prevention in HPV transmission with exogenous reinfection.
    PLoS One. 2025;20:e0327233.
    >> Share

  47. MREMI A, Joseph AP, Njunwa DV, Ntupwa DA, et al
    Knowledge, attitude and practices towards cervical cancer control among University students in Kilimanjaro region, Tanzania.
    PLoS One. 2025;20:e0327879.
    >> Share

  48. AGHA S, Nsofor I
    HPV vaccine uptake among adolescent girls in Nigeria: The complex role of caregivers' education.
    PLoS One. 2025;20:e0325684.
    >> Share

  49. LIU Q, Peng Y, Liu W, Luo X, et al
    SERPINH1 functions as a multifunctional regulator to promote the malignant progression of cervical cancer.
    PLoS One. 2025;20:e0329007.
    >> Share

  50. MENGISTIE BA, Melese M, Gebiru AM, Getnet M, et al
    Uptake of cervical cancer screening and its determinants in Africa: Umbrella review.
    PLoS One. 2025;20:e0328103.
    >> Share

  51. MREMA A, Ngoma M, Lugina EL, Kahakwa A, et al
    Genotype distribution of human papillomavirus among women with cervical cancer stratified by HIV status in Tanzania.
    PLoS One. 2025;20:e0322311.
    >> Share

  52. KHATRI RB, Endalamaw A, Darssan D, Assefa Y, et al
    A scoping review of the levels, implementation strategies, enablers, and barriers to cervical, breast, and colorectal cancer screening among migrant populations in selected English-speaking high-income countries.
    PLoS One. 2025;20:e0329854.
    >> Share

  53. KASSA B, Mohammed A, Wassie GT
    Parents' acceptance of human papilloma virus vaccination for their daughters in adet town, North Gojjam zone, Northwest Ethiopia: A mixed method study.
    PLoS One. 2025;20:e0330911.
    >> Share

  54. DEN'O ZD, Paulos W, Markos D, Oche WO, et al
    Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
    PLoS One. 2025;20:e0330760.
    >> Share

  55. BULAMBA RM, Kyasanku E, Nalugoda F, Daama A, et al
    Assessing Knowledge, Uptake and Factors associated with cervical cancer screening among women in selected communities of Wakiso district in Uganda: A population-based study.
    PLoS One. 2025;20:e0317641.
    >> Share

  56. OLUBODUN T, Olaniran A, Awowole IO, Ohazurike E, et al
    Practice of opportunistic cervical cancer screening and health education among health workers in Ogun State, Nigeria: A qualitative study of barriers and facilitators.
    PLoS One. 2025;20:e0316883.
    >> Share

  57. MWANGI JH, Mbeje PN, Mtshali GN
    Exploring the roles of male partners in the transmission, prevention and control of cervical cancer in Central Kenya: A qualitative study.
    PLoS One. 2025;20:e0324575.
    >> Share

  58. JAFRIN S, Aziz MA, Barek MA, Reza MS, et al
    Association of missense variant DCLRE1B rs3761936 with breast and cervical cancer risk-A case-control study.
    PLoS One. 2025;20:e0331492.
    >> Share

  59. WYNN A, Harris D, Modest A, Reyes MF, et al
    Short-term costs and cost-efficiency of HPV triage strategies in a high HIV-prevalence setting: Evidence from Botswana.
    PLoS One. 2025;20:e0328803.
    >> Share

  60. KHIRUDDIN K, Mustafa WA, Islam MA, Jamaludin KR, et al
    Comparative analysis of cervical cancer classification of DPAGCHE-enhanced Pap smear images using convolutional neural network models.
    PLoS One. 2025;20:e0330103.
    >> Share

  61. CHEN D, Wu H, Huang F, Tan K, et al
    Prognostic follow-up of high-grade squamous intraepithelial lesions of the cervix near the conization margin: A retrospective cohort study.
    PLoS One. 2025;20:e0331184.
    >> Share

  62. BASHORUN AO, Kotei L, Jallow AF, Jawla O, et al
    Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocol.
    PLoS One. 2025;20:e0332842.
    >> Share

    January 2024
  63. ALJREES T
    Improving prediction of cervical cancer using KNN imputer and multi-model ensemble learning.
    PLoS One. 2024;19:e0295632.
    >> Share

  64. MUNSHI RM
    Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
    PLoS One. 2024;19:e0296107.
    >> Share

  65. YU C, Wu X, Zhang S, Zhang L, et al
    Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study.
    PLoS One. 2024;19:e0296446.
    >> Share

  66. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    >> Share

  67. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    >> Share

  68. KANG SW, Kang OJ, Lee JY, Kim H, et al
    Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
    PLoS One. 2024;19:e0298815.
    >> Share

  69. MANGENAH C, Sibanda EL, Maringwa G, Sithole J, et al
    Provider and female client economic costs of integrated sexual and reproductive health and HIV services in Zimbabwe.
    PLoS One. 2024;19:e0291082.
    >> Share

  70. MUNSHI RM
    Correction: Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
    PLoS One. 2024;19:e0298980.
    >> Share

  71. VARON ML, Geng Y, Fellman BM, Troisi C, et al
    Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.
    PLoS One. 2024;19:e0291931.
    >> Share

  72. YAO B, Peng J, Song W, Yang L, et al
    Real-world effectiveness of cytology and HPV-based screening strategy in cervical cancer screening: A cross-sectional population-based study in Chengdu, China.
    PLoS One. 2024;19:e0299651.
    >> Share

  73. SUN J, Frick KD, Liang H, Chow CM, et al
    Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
    PLoS One. 2024;19:e0290105.
    >> Share

  74. ZHANG J, Yuan J, Zhang D, Yang Y, et al
    Short video platforms as sources of health information about cervical cancer: A content and quality analysis.
    PLoS One. 2024;19:e0300180.
    >> Share

  75. CAROZZI FM, Royder Yanez R, Paganini I, Sani C, et al
    Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
    PLoS One. 2024;19:e0292605.
    >> Share

  76. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    >> Share

  77. LIN Y, Long Y, He J, Yi Q, et al
    The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    PLoS One. 2024;19:e0298520.
    >> Share

  78. OOMMEN AM, Isaac R, Paul B, Weller D, et al
    Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
    PLoS One. 2024;19:e0301385.
    >> Share

  79. LEMLEM SB, Gary RA, Yeager KA, Sisay MM, et al
    Psychometric properties of a modified health belief model for cervical cancer and visual inspection with acetic acid among healthcare professionals in Ethiopia.
    PLoS One. 2024;19:e0295905.
    >> Share

  80. KHUMALO PG, Carey M, Mackenzie L, Sanson-Fisher R, et al
    Cervical cancer screening knowledge and associated factors among Eswatini women: A cross-sectional study.
    PLoS One. 2024;19:e0300763.
    >> Share

  81. DUA R, Bhardwaj T, Ahmad I, Somvanshi P, et al
    Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach.
    PLoS One. 2024;19:e0287864.
    >> Share

  82. ZEBER-LUBECKA N, Kulecka M, Dabrowska M, Baginska-Drabiuk K, et al
    Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.
    PLoS One. 2024;19:e0302270.
    >> Share

  83. XU F, Carlson SA, Greenlund KJ
    Understanding primary care providers' attitudes towards preventive screenings to patients with inflammatory bowel disease.
    PLoS One. 2024;19:e0299890.
    >> Share

  84. MOSHI JM, Ummelen M, Smedts F, Ramaekers FCS, et al
    Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
    PLoS One. 2024;19:e0297008.
    >> Share

  85. TIRKASO BH, Bayisa TH, Desta TW
    Histopathologic patterns and factors associated with cervical lesions at Jimma Medical Center, Jimma, Southwest Ethiopia: A two-year cross-sectional study.
    PLoS One. 2024;19:e0301559.
    >> Share

  86. WANG QL, Gong C, Meng XY, Fu M, et al
    TPP1 is associated with risk of advanced precursors and cervical cancer survival.
    PLoS One. 2024;19:e0298118.
    >> Share

  87. SHIMELS T, Gashawbeza B, Fenta TG
    Validation of the Amharic version of perceived access to healthcare services for patients with cervical cancer in Ethiopia: A second-order confirmatory factor analysis.
    PLoS One. 2024;19:e0300815.
    >> Share

  88. ILIKA CP, Eleje GU, Chiemeka ME, Ilika FN, et al
    Effects of speculum lubrication on cervical smears for cervical cancer screening: A double blind randomized clinical trial.
    PLoS One. 2024;19:e0292207.
    >> Share

  89. BROSHKEVITCH CJ, Barnabas RV, Liu G, Palanee-Phillips T, et al
    Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
    PLoS One. 2024;19:e0301997.
    >> Share

  90. HUSSEIN K, Kokwaro G, Wafula F, Kassie GM, et al
    Assessing the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.
    PLoS One. 2024;19:e0300152.
    >> Share

  91. AGYARE GYANE F, Modey E, Maya E, Bonney EY, et al
    Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
    PLoS One. 2024;19:e0303535.
    >> Share

  92. KIM JY, Jung JH, Jung S, Lee S, et al
    Glyoxalase 1: Emerging biomarker and therapeutic target in cervical cancer progression.
    PLoS One. 2024;19:e0299345.
    >> Share

  93. WANG Q, Xu M, Zhou H, Li Y, et al
    Prevalence characteristics of cervical human papillomavirus infection in Chengdu and Aba District, Sichuan Province, China.
    PLoS One. 2024;19:e0304760.
    >> Share

  94. TONG Y, Jia L, Li M, Li H, et al
    Identification of exosomal circSLC26A4 as a liquid biopsy marker for cervical cancer.
    PLoS One. 2024;19:e0305050.
    >> Share

  95. TSIMA BM, Motlhatlhedi K, Sharma K, Rantshabeng P, et al
    The association between smoking and cervical human papillomavirus infection among women from indigenous communities in western Botswana.
    PLoS One. 2024;19:e0302153.
    >> Share

  96. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
    Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
    PLoS One. 2024;19:e0306044.
    >> Share

  97. GONG S, Li G, Li D, Liu Y, et al
    The risk for subsequent primary lung cancer after cervical carcinoma: A quantitative analysis based on 864,627 cases.
    PLoS One. 2024;19:e0305670.
    >> Share

  98. QI J, Li J, Zhu X, Zhao S, et al
    Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1.
    PLoS One. 2024;19:e0304597.
    >> Share

  99. JIN S, Lin F, Yang L, Zhang Q, et al
    Association between dietary folate intake and HPV infection: NHANES 2005-2016.
    PLoS One. 2024;19:e0306636.
    >> Share

  100. CASTELLANO T, ElHabr AK, Washington C, Ting J, et al
    Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US.
    PLoS One. 2024;19:e0307282.
    >> Share

  101. BALQIS-ALI NZ, Anis-Syakira J, Fun WH, Mohd Said Z, et al
    Achieving cervical cancer elimination: The simulated impacts of HPV vaccination and transitioning from liquid-based cytology to HPV-based screening test.
    PLoS One. 2024;19:e0307880.
    >> Share


  102. Retraction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis.
    PLoS One. 2024;19:e0308113.
    >> Share

  103. MUCHAILI L, Simushi P, Mweene BC, Mwakyoma T, et al
    Prevalence and correlates of Human Papillomavirus infection in females from Southern Province, Zambia: A cross-sectional study.
    PLoS One. 2024;19:e0299963.
    >> Share

  104. LORDELO MV, Oliveira CZ, Aguirre Buexm L, Vieira Reis RM, et al
    Randomized experimental population-based study to evaluate the acceptance and completion of and preferences for cervical cancer screening.
    PLoS One. 2024;19:e0306130.
    >> Share

  105. NAZRUL N, de Fouw M, Beltman JJ, de Zeeuw J, et al
    Understanding cervical cancer awareness in hard-to-reach areas of Bangladesh: A cross-sectional study involving women and household decisionmakers.
    PLoS One. 2024;19:e0304396.
    >> Share

  106. GOLALIPOUR A, Mohammadi A, Hosseinzadeh S, Soltani A, et al
    Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells.
    PLoS One. 2024;19:e0308599.
    >> Share

  107. HARIPRASAD R, Bagepally BS, Kumar S, Pradhan S, et al
    Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023.
    PLoS One. 2024;19:e0300556.
    >> Share

  108. GOMES FC, Galhardo DDR, Navegante ACG, Santos GSD, et al
    Bioinformatics analysis to identify the relationship between human papillomavirus-associated cervical cancer, toll-like receptors and exomes: A genetic epidemiology study.
    PLoS One. 2024;19:e0305760.
    >> Share

  109. ROMLI R, Mohamad EMW, Abd Rahman R, Chew KT, et al
    Validation and usability of SeDAR e-health video for enhancing cervical cancer screening.
    PLoS One. 2024;19:e0310555.
    >> Share

  110. ROBLEDO-CADENA DX, Pacheco-Velazquez SC, Vargas-Navarro JL, Padilla-Flores JA, et al
    Synergistic celecoxib and dimethyl-celecoxib combinations block cervix cancer growth through multiple mechanisms.
    PLoS One. 2024;19:e0308233.
    >> Share

  111. DANTAS DM, de Souza ATB, de Araujo Santos Camargo JD, Costa APF, et al
    Efficacy and safety of pembrolizumab in cervical cancer: Protocol for systematic review and meta-analysis of randomized clinical trials.
    PLoS One. 2024;19:e0312004.
    >> Share

  112. TWABI HH, Msosa TC, Meja SJ, Mukoka M, et al
    Spatial distribution and characteristics of women reporting cervical cancer screening in Malawi: An analysis of the 2020 to 2021 Malawi Population-based HIV Impact Assessment survey data.
    PLoS One. 2024;19:e0309053.
    >> Share

  113. SUTHERLAND EK, Smith JD, Ofori-Boateng M, Kushitor SB, et al
    Study protocol for the development of a real-time interface showing the availability of breast and cervical cancer services in Ghana.
    PLoS One. 2024;19:e0312150.
    >> Share

  114. RONG Y, Yang Y, Zhang X, Zhou X, et al
    Pain scores reduction with the use of ultrasound-guided paracervical nerve block in patients with cervical cancer undergoing intracavitary brachytherapy: A randomized controlled trial.
    PLoS One. 2024;19:e0310238.
    >> Share

  115. SULTANOV M, Koot JAR, de Bock GH, Greuter MJW, et al
    High-risk human papillomavirus testing for cervical cancer screening in Uganda: Considering potential harms and benefits in a low-resource setting.
    PLoS One. 2024;19:e0312295.
    >> Share

  116. LAHOLE BK, Woldamlak M, Kussia W
    Determinants of cervical cancer screening intention among reproductive age women in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312449.
    >> Share

  117. ILIC I, Babic G, Dimitrijevic A, Grujicic SS, et al
    Detecting the impact of diagnostic procedures in Pap-positive women on anxiety using artificial neural networks.
    PLoS One. 2024;19:e0312870.
    >> Share

  118. BIRARA M, Urgie T, Sium AF
    Locally advanced cervical cancer: Neoadjuvant chemotherapy plus radical surgery an alternative approach to chemo-radiation in a low-income setting: A descriptive study.
    PLoS One. 2024;19:e0310457.
    >> Share

  119. CAMPUZANO TMF, Borba MACSM, de Mendonca Batista P, Nadalin M, et al
    Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system.
    PLoS One. 2024;19:e0312757.
    >> Share

  120. AREVALOS A, Valenzuela A, Mongelos P, Barrios H, et al
    Genital infections in high-risk human papillomavirus positive Paraguayan women aged 30-64 with and without cervical lesions.
    PLoS One. 2024;19:e0312947.
    >> Share

  121. BAWALLE AA, Nguyen TXT, Khan MSR, Kadoya Y, et al
    Impact of financial literacy and education on breast and cervical cancer screening participation in Japan.
    PLoS One. 2024;19:e0313687.
    >> Share

  122. PLISKO O, Zodzika J, Jermakova I, Pcolkina K, et al
    Prediction of high-grade cervical precancerous abnormalities: The role of personal factors, vaginal microflora, sexually transmitted infections, and high-risk human papillomavirus.
    PLoS One. 2024;19:e0313004.
    >> Share

  123. ABDULL RAHIM U, Mustapa M, Mohamed Shakrin NNS, Nurdin A, et al
    Current evidence and future direction on evaluating the anticancer effects of curcumin, gingerols, and shogaols in cervical cancer: A systematic review.
    PLoS One. 2024;19:e0314280.
    >> Share

  124. DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
    Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia.
    PLoS One. 2024;19:e0310591.
    >> Share

  125. OWARE J, Iddrisu M, Konlan KD, Dzansi G, et al
    Personal and workplace factors influencing the resilience of nurses caring for women with cervical cancer in a resource-constrained setting in Ghana.
    PLoS One. 2024;19:e0314764.
    >> Share

  126. WANG J, Lu Y, Li F, Yao D, et al
    Preserving circumflex iliac lymph nodes to reduce the incidence of lower limb lymphedema following lymphadenectomy in cervical and endometrial cancers: A prospective randomized controlled trial.
    PLoS One. 2024;19:e0311144.
    >> Share

  127. ASGEDOM YS, Hailegebireal AH, Woldegeorgis BZ, Koyira MM, et al
    Towards 90-70-90 targets: Individual and community level factors associated with cervical cancer screening among women of reproductive age in Tanzania: A multi-level analysis based on 2022 Tanzania demographic and health survey.
    PLoS One. 2024;19:e0315438.
    >> Share

  128. CHAKRABORTY S, Nessa A, Ferdous NE, Rahman MM, et al
    Prevalence and genotypic distribution of high-risk human papillomavirus (HPV) among ever-married women in coastal regions of Bangladesh.
    PLoS One. 2024;19:e0313396.
    >> Share

  129. LIM C, Seo YJ, Lee JY, Jung ES, et al
    Evaluation of the cervical liquid-based cytology sample as a microbiome resource for dual diagnosis.
    PLoS One. 2024;19:e0308985.
    >> Share

  130. CAO Q, Hou Y, Wang C, Yin J, et al
    Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312128.
    >> Share

  131. BHENGU P, Ndwandwe D, Cooper S, Katoto PDMC, et al
    Behavioural and social drivers of human papillomavirus vaccination in eThekwini District of KwaZulu-Natal Province, South Africa.
    PLoS One. 2024;19:e0311509.
    >> Share

  132. OHYA A, Miyamoto T, Ichinohe F, Kobara H, et al
    Problems of magnetic resonance diagnosis for gastric-type mucin-positive cervical lesions of the uterus and its solutions using artificial intelligence.
    PLoS One. 2024;19:e0315862.
    >> Share

    January 2023
  133. RODRIGUEZ NM, Brennan LP, Claure L, Balian LN, et al
    Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    PLoS One. 2023;18:e0282853.
    >> Share

  134. YAN L, Xiao X, He L, Shi L, et al
    Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
    PLoS One. 2023;18:e0282833.
    >> Share

  135. CHOI J, Markham C, Tami-Maury I, Kim S, et al
    Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
    PLoS One. 2023;18:e0282811.
    >> Share

  136. GIBSON-HELM M, Slater T, MacDonald EJ, Stevenson K, et al
    Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
    PLoS One. 2023;18:e0280643.
    >> Share

  137. SMITH JS, Vaz OM, Gaber CE, Des Marais AC, et al
    Recruitment strategies and HPV self-collection return rates for under-screened women for cervical cancer prevention.
    PLoS One. 2023;18:e0280638.
    >> Share

  138. TAKADA A, Yokota H, Nemoto MW, Horikoshi T, et al
    Prognosis prediction of uterine cervical cancer using changes in the histogram and texture features of apparent diffusion coefficient during definitive chemoradiotherapy.
    PLoS One. 2023;18:e0282710.
    >> Share

  139. PAKEN J, Govender CD, Pillay M, Feyasa M, et al
    Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
    PLoS One. 2023;18:e0283639.
    >> Share

  140. LIVESEY M, Rossouw SC, Blignaut R, Christoffels A, et al
    Transforming RNA-Seq gene expression to track cancer progression in the multi-stage early to advanced-stage cancer development.
    PLoS One. 2023;18:e0284458.
    >> Share


  141. Expression of Concern: Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis.
    PLoS One. 2023;18:e0285579.
    >> Share

  142. HOLOPAINEN E, Lahtinen O, Kononen M, Anttila M, et al
    Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer.
    PLoS One. 2023;18:e0285786.
    >> Share

  143. OKAFOR IP, Kukoyi FO, Kanma-Okafor OJ, Izuka MO, et al
    Male involvement in female partners' screening for breast and cervical cancers in Southwest Nigeria.
    PLoS One. 2023;18:e0284141.
    >> Share

  144. MITI S, Shato T, Asante C, Baumann A, et al
    Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
    PLoS One. 2023;18:e0285031.
    >> Share

  145. KHOMPHAIBOONKIJ U, Sreamsukcharoenchai N, Pitakkarnkul S, Rittiluechai K, et al
    Knowledge of Thai women in cervical cancer etiology and screening.
    PLoS One. 2023;18:e0286011.
    >> Share

  146. KURITA Y, Meguro S, Tsuyama N, Kosugi I, et al
    Accurate deep learning model using semi-supervised learning and Noisy Student for cervical cancer screening in low magnification images.
    PLoS One. 2023;18:e0285996.
    >> Share

  147. PANERU B, Karmacharya A, Bharati A, Makaju S, et al
    Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal.
    PLoS One. 2023;18:e0285771.
    >> Share

  148. JEMAL Z, Chea N, Hasen H, Tesfaye T, et al
    Cervical cancer screening utilization and associated factors among female health workers in public health facilities of Hossana town, southern Ethiopia: A mixed method approach.
    PLoS One. 2023;18:e0286262.
    >> Share

  149. MWENDA V, Bor JP, Nyangasi M, Njeru J, et al
    Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
    PLoS One. 2023;18:e0286202.
    >> Share

  150. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    PLoS One. 2023;18:e0286909.
    >> Share

  151. ALAM Z, Cairns JM, Scott M, Dean JA, et al
    Interventions to increase cervical screening uptake among immigrant women: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281976.
    >> Share

  152. VAINER G, Huang L, Emancipator K, Nuti S, et al
    Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
    PLoS One. 2023;18:e0285764.
    >> Share

  153. JONSDOTTIR B, Wikman A, Sundstrom Poromaa I, Stalberg K, et al
    Advanced gynecological cancer: Quality of life one year after diagnosis.
    PLoS One. 2023;18:e0287562.
    >> Share

  154. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
    Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
    PLoS One. 2023;18:e0287295.
    >> Share

  155. WULANDARI D, Meidyandra RW, Andrijono
    Genotype profiles of high-risk human papillomavirus in women of reproductive age: A community-based study.
    PLoS One. 2023;18:e0287399.
    >> Share

  156. MAHAJAN H, Reddy N, Devi NGM, Poli UR, et al
    Projected cancer burden, challenges, and barriers to cancer prevention and control activities in the state of Telangana.
    PLoS One. 2023;18:e0278357.
    >> Share

  157. FAZLOLLAHPOUR-NAGHIBI A, Bagheri K, Almukhtar M, Taha SR, et al
    Trichomonas vaginalis infection and risk of cervical neoplasia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0288443.
    >> Share

  158. BAS S, Sijben J, Bischoff EWMA, Bekkers RLM, et al
    Acceptability of risk-based triage in cervical cancer screening: A focus group study.
    PLoS One. 2023;18:e0289647.
    >> Share

  159. CONTRERAS NE, Roldan JS, Castillo DS
    Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein.
    PLoS One. 2023;18:e0290088.
    >> Share

  160. CHONA EZ, Msengi EA, Gosse RA, Ambikile JS, et al
    The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania.
    PLoS One. 2023;18:e0289925.
    >> Share

  161. OKYERE ASANTE PG, Owusu AY, Oppong JR, Amegah KE, et al
    The psychosocial burden of women seeking treatment for breast and cervical cancers in Ghana's major cancer hospitals.
    PLoS One. 2023;18:e0289055.
    >> Share

  162. GONG M, Shen F, Li Y, Ming L, et al
    MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
    PLoS One. 2023;18:e0290462.
    >> Share

  163. URQUHART G, Maclennan SJ, Guntupalli AM
    Is there an association between intimate partner violence and the prevalence of cervical cancer screening in Jordan?
    PLoS One. 2023;18:e0290678.
    >> Share

  164. SUNDARA RAJAN R S, Thomas J, Francis D, Daniel EC, et al
    Effective gene delivery using size dependant nano core-shell in human cervical cancer cell lines by magnetofection.
    PLoS One. 2023;18:e0289731.
    >> Share

  165. ODEH HI, Al-Badi SR, Karima B, Saeed TA, et al
    Exploring the prevalence of Human Papillomavirus (HPV) genotypes in PAP smear samples of women in northern region of United Arab Emirates (UAE): HPV Direct Flow CHIP system-based pilot study.
    PLoS One. 2023;18:e0286889.
    >> Share

  166. WANG S, Wang Y, Zhuang J, Wu Y, et al
    Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer.
    PLoS One. 2023;18:e0290905.
    >> Share

  167. MANTULA F, Toefy Y
    Women and health providers' perspectives on male support for cervical cancer screening in Gwanda district, Zimbabwe.
    PLoS One. 2023;18:e0282931.
    >> Share

  168. IORDANISHVILI S, Metreveli T, Lipartia E, Gachechiladze K, et al
    The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development.
    PLoS One. 2023;18:e0291725.
    >> Share

  169. FERREIRA HNC, Capistrano GN, Morais TNB, Costa KTDS, et al
    Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
    PLoS One. 2023;18:e0278011.
    >> Share

  170. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
    Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
    PLoS One. 2023;18:e0291643.
    >> Share

  171. ZHAO X, Gopalappa C
    Joint modeling HIV and HPV using a new hybrid agent-based network and compartmental simulation technique.
    PLoS One. 2023;18:e0288141.
    >> Share

  172. DESTA M, Getaneh T, Yeserah B, Worku Y, et al
    Correction: Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0294799.
    >> Share

  173. TACHIWENYIKA E, Dhodho M, Muchedzi A, Sibanda TP, et al
    Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
    PLoS One. 2023;18:e0294115.
    >> Share

  174. MAHUMUD RA, Alam K, Dunn J, Gow J, et al
    Correction: The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.
    PLoS One. 2023;18:e0295688.
    >> Share

  175. QULU W, Mtshali A, Osman F, Ndlela N, et al
    High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
    PLoS One. 2023;18:e0294698.
    >> Share

  176. ALMASOUDI HH, Nahari MH, Alhazmi AYM, Almasabi SHA, et al
    Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
    PLoS One. 2023;18:e0295714.
    >> Share

  177. RAZZAK MA, Islam MN, Aadeeb MS, Tasnim T, et al
    Digital health interventions for cervical cancer care: A systematic review and future research opportunities.
    PLoS One. 2023;18:e0296015.
    >> Share

  178. AL-OSEELY S, Abdul Manaf R, Ismail S
    Factors affecting cervical cancer screening among Yemeni immigrant women in Klang Valley, Malaysia: A cross sectional study.
    PLoS One. 2023;18:e0290152.
    >> Share

  179. GEBREMESKEL TG, Gebretatios MZ
    Determinants of cervical cancer screening utilization among HIV-positive women, in public general hospitals of Central Zone, Tigray, Ethiopia, 2020: Case-control study.
    PLoS One. 2023;18:e0289042.
    >> Share

  180. NOVAIS IR, Coelho CO, Machado HC, Surita F, et al
    Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.
    PLoS One. 2023;18:e0294956.
    >> Share

  181. TOSADO-RODRIGUEZ E, Mendez LB, Espino AM, Dorta-Estremera S, et al
    Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
    PLoS One. 2023;18:e0284673.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016